Abiopharma

🔍 Garabedian Raffi (Executive)

Company: ESS Tech, Inc. (GWH)

Report Date: 2026-05-29

Detailed Transactions and Holdings:

• Acquired 13,513 shares of Common Stock (Direct)
  Date: 2026-05-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 53,185.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The reported shares are represented by restricted stock units ("RSUs"), which vest on the earlier of (i) May 29, 2027 or (ii) the day prior to the next annual meeting of stockholders. The Reporting Person has elected to defer the settlement of these RSUs to a date within 30 days of the earlier of (i) his separation of service from the Issuer within the meaning of Section 409A of the Internal Revenue Code (Section 409A) or (ii) the date on which a change of control (as defined in the Issuer's plan) occurs, provided that such transaction qualifies as a change of control within the meaning of Section 409A.
• F2: A portion of these securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.